Vascular endothelial growth factor is modulated in vascular muscle cells by estradiol, tamoxifen, and hypoxia

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 279, Issue 5 48-5, 2000, Pages

  Bausero, P ^a   Ben Mahdi, M H ^a   Mazucatelli, J P ^a   Bloy, C ^a   Perrot Applanat, M ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

Human; Saphenous vein; Vascular smooth muscle cells

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; TAMOXIFEN; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; FIBROBLAST; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; IMMUNOCYTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSLATION; SAPHENOUS VEIN; VASCULAR SMOOTH MUSCLE;

EID: 0033668125     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.2000.279.5.h2033     Document Type: Article

References (58)

1. Inhibition of coronary atherosclerosis by 17β-estradiol in ovariectomized monkeys
2. Upregulation of vascular endothelial growth factor expression induced by myocardial ischemia: Implication for coronary angiogenesis
3. Paracrine action of vascular endothelial growth factor in the human endometrium: Production and target sites, and hormonal regulation
4. Estrogen synthesis, estrogen metabolism and functional receptors in rat arterial smooth muscle cells in culture
5. Control of transcription by steroid hormones
6. Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only
7. Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression
8. Identification and localization of alternately spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines
9. Vascular permeability factor: A tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity and promotes monocyte migration
10. Vascular endothelial growth factor/vascular permeability factor expression on the rat uterus: Rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth
11. 17β-Estradiol inhibits proliferation and migration of human vascular smooth muscle cells: Similar effects in cells from postmenopausal females and males
12. Vascular permeability factor/vascular endothelial growth factor, microvascular hypermeability, and angiogenesis
13. The steroid and thyroid hormone receptor superfamily
14. The vascular protective effects of estrogen
15. The biology of vascular endothelial growth factor
16. Aortic smooth muscle cells express and secrete vascular endothelial growth factor
17. Tamoxifen decreases the rate of proliferation of rat vascular smooth muscle cells in culture by inducing production of transforming growth factor β
18. Human oestrogen receptor cDNA: Sequence, expression and homology to v-erb-A
19. Uterine expression of vascular endothelial growth factor is increased by estradiol and tamoxifen
20. Estrogen inhibits the vascular injury response in estrogen receptor α-deficient mice
21. Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions. Possible pathophysiological significance of VEGF in progresssion of atherosclerosis
22. Disruption of estrogen receptor prevents 17β estradiol-induced angiogenesis in transgenic mice
23. Tamoxifen, raloxifene, and the prevention of breast cancer
24. Human vascular smooth muscle cells contain functional estrogen receptor
25. Estradiol accelerates functional endothelial recovery after arterial injury
26. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors sand β
27. Induction of vascular endothelial growth factor expression by interleukin-1β in rat aortic smooth muscle cells
28. VEGF induces NO-dependent hyperpermeability in coronary venules
29. Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and a in a murine model
30. ERβ: Identification and characterization of a novel human estrogen receptor
31. An alternative quantitative polymerase chain reaction method
32. Vascular smooth muscle cells as target for estrogens
33. Differential ligand activation of estrogen receptors ERα and ERβ at AP 1 sites
34. Hypoxia increases vasodilator release from internal mammary artery and saphenous vein grafts
35. Estrogen receptors in the cardiovascular system
36. Progesterone receptor expression in human saphenous veins
37. Immunohistochemical localization of estradiol and progesterone receptors in human uterus throughout pregnancy. Expression in endometrial blood vessels
38. Immunocytochemical demonstration of oestrogen and progesterone receptors in muscle cells of uterine arteries in rabbits and humans
39. The cytoskeleton and the cellular traffic of the progesterone receptor
40. Vascular endothelial growth factor is induced in response to transforming growth factor-β in fibroblastic and epithelial cells
41. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization
42. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human glioma in vivo
43. Extracellular cleavage of the vascular endothelial growth factor family 189 as a form by urokinase is required for its mitogenic effect
44. Regulation of vascular endothelial growth factor expression by cAMP in rat aortic smooth muscle cells
45. Tamoxifen decreases cholesterol sevenfold and abolishes lipid lesion development in apolipoprotein E knockout mice
46. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor
47. Oestrogen receptor beta (ERβ)
48. A requirement for Flk- 1 in primitive and definitive hematopoiesis and vasculogenesis
49. Ovarian steroid regulation of vascular endothelial growth factor in human endometrium: Implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis
50. Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis
51. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
52. Estradiol receptor mediated inhibition of human endothelial cell apoptosis. Estradiol as a survival factor
53. Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells. Synergistic interaction with hypoxia
54. The human gene for vascular endothelial growth factor: Multiple protein are encoded through alternative exon splicing
55. Estrogen, progesterone and vascular reactivity: Potential cellular mechanisms
56. Structure and function of vasa vasorum
57. Tamoxifen inhibits arterial accumulation of LDL degradation products and progression of coronary atherosclerosis in monkeys
58. Nitric oxide synthase lies down-stream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis